Cargando…
Best practices for the analytical validation of clinical whole-genome sequencing intended for the diagnosis of germline disease
Whole-genome sequencing (WGS) has shown promise in becoming a first-tier diagnostic test for patients with rare genetic disorders; however, standards addressing the definition and deployment practice of a best-in-class test are lacking. To address these gaps, the Medical Genome Initiative, a consort...
Autores principales: | Marshall, Christian R., Chowdhury, Shimul, Taft, Ryan J., Lebo, Mathew S., Buchan, Jillian G., Harrison, Steven M., Rowsey, Ross, Klee, Eric W., Liu, Pengfei, Worthey, Elizabeth A., Jobanputra, Vaidehi, Dimmock, David, Kearney, Hutton M., Bick, David, Kulkarni, Shashikant, Taylor, Stacie L., Belmont, John W., Stavropoulos, Dimitri J., Lennon, Niall J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585436/ https://www.ncbi.nlm.nih.gov/pubmed/33110627 http://dx.doi.org/10.1038/s41525-020-00154-9 |
Ejemplares similares
-
The Medical Genome Initiative: moving whole-genome sequencing for rare disease diagnosis to the clinic
por: Marshall, Christian R., et al.
Publicado: (2020) -
Clinical utility of genomic sequencing: a measurement toolkit
por: Hayeems, Robin Z., et al.
Publicado: (2020) -
Best practices for the interpretation and reporting of clinical whole genome sequencing
por: Austin-Tse, Christina A., et al.
Publicado: (2022) -
Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases
por: Bick, David, et al.
Publicado: (2019) -
Deciding Without Intending
por: Nolte, Alexandra, et al.
Publicado: (2020)